Application of Monocyte-to-Albumin Ratio and Neutrophil Percentage-to-Hemoglobin Ratio on Distinguishing Non-Small Cell Lung Cancer Patients from Healthy Subjects

References

• Nooreldeen R, Bach H. Current and future development in lung cancer diagnosis. Int J Mol Sci. 2021;22(16):8661. doi:10.3390/ijms22168661
   PubMed Web of Science ®Google Scholar
• Alberg AJ, Brock MV, Samet JM. Epidemiology of lung cancer: looking to the future. J Clin Oncol. 2005;23(14):3175–3185. doi:10.1200/JCO.2005.10.462
   PubMed Web of Science ®Google Scholar
• Planchard D, Popat S, Kerr K, et al; ESMO guidelines Committee. Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv192–iv237. doi:10.1093/annonc/mdy275
   PubMed Web of Science ®Google Scholar
• Alexander M, Kim SY, Cheng H. Update 2020: management of non-small cell lung cancer. Lung. 2020;198(6):897–907. doi:10.1007/s00408-020-00407-5
   PubMed Web of Science ®Google Scholar
• Pillai RN, Ramalingam SS. Advances in the diagnosis and treatment of non-small cell lung cancer. Mol Cancer Ther. 2014;13(3):557–564. doi:10.1158/1535-7163.MCT-13-0669
   PubMed Web of Science ®Google Scholar
• Toyoda Y, Nakayama T, Kusunoki Y, et al. Sensitivity and specificity of lung cancer screening using chest low-dose computed tomography. Br J Cancer. 2008;98(10):1602–1607. doi:10.1038/sj.bjc.6604351
   PubMed Web of Science ®Google Scholar
• Sobue T, Moriyama N, Kaneko M, et al. Screening for lung cancer with low-dose helical computed tomography: anti-lung cancer association project. J Clin Oncol. 2002;20(4):911–920. doi:10.1200/JCO.2002.20.4.911
   PubMed Web of Science ®Google Scholar
• Cho WC. Potentially useful biomarkers for the diagnosis, treatment and prognosis of lung cancer. Biomed Pharmacother. 2007;61(9):515–519. doi:10.1016/j.biopha.2007.08.005
   PubMed Web of Science ®Google Scholar
• Grunnet M, Sorensen JB. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer. 2012;76(2):138–143. doi:10.1016/j.lungcan.2011.11.012
   PubMed Web of Science ®Google Scholar
• Chevinsky AH. CEA in tumors of other than colorectal origin. Semin Surg Oncol. 1991;7(3):162–166. doi:10.1002/ssu.2980070309
   PubMedGoogle Scholar
• Kim J, Bae JS. Tumor-associated macrophages and neutrophils in tumor microenvironment. Mediators Inflamm. 2016;2016:6058147. doi:10.1155/2016/6058147
   PubMed Web of Science ®Google Scholar
• Chen JL, Wu JN, Lv XD, et al. The value of red blood cell distribution width, neutrophil-to-lymphocyte ratio, and hemoglobin-to-red blood cell distribution width ratio in the progression of non-small cell lung cancer. PLoS One. 2020;15(8):e0237947. doi:10.1371/journal.pone.0237947
   PubMed Web of Science ®Google Scholar
• Lin Z, Zhang X, Luo Y, et al. The value of hemoglobin-to-red blood cell distribution width ratio (Hb/RDW), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) for the diagnosis of nasopharyngeal cancer. Medicine. 2021;100(28):e26537. doi:10.1097/MD.0000000000026537
   PubMed Web of Science ®Google Scholar
• Li X, Guo D, Chu L, et al. Potential diagnostic value of combining inflammatory cell ratios with carcinoembryonic antigen for colorectal cancer. Cancer Manag Res. 2019;11:9631–9640. doi:10.2147/CMAR.S222756
   PubMed Web of Science ®Google Scholar
• Chen Y, Song Y, Du W, et al. Tumor-associated macrophages: an accomplice in solid tumor progression. J Biomed Sci. 2019;26(1):78. doi:10.1186/s12929-019-0568-z
   PubMed Web of Science ®Google Scholar
• Xu SS, Li S, Xu HX, et al. Haemoglobin, albumin, lymphocyte and platelet predicts postoperative survival in pancreatic cancer. World J Gastroenterol. 2020;26(8):828–838. doi:10.3748/wjg.v26.i8.828
   PubMed Web of Science ®Google Scholar
• Zhang J, Li SQ, Liao ZH, et al. Prognostic value of a novel FPR biomarker in patients with surgical stage II and III gastric cancer. Oncotarget. 2017;8(43):75195–75205. doi:10.18632/oncotarget.20661
   PubMedGoogle Scholar
• Zhang L, Qin S, Lu L, et al. Diagnostic value of combined prealbumin-to-fibrinogen and albumin-to-fibrinogen ratios in Hp-negative gastric cancer. Int J Biol Markers. 2022;37(1):66–73. doi:10.1177/17246008211072875
   PubMed Web of Science ®Google Scholar
• Detterbeck FC, Boffa DJ, Kim AW, et al. The eighth edition lung cancer stage classification. Chest. 2017;151(1):193–203. doi:10.1016/j.chest.2016.10.010
   PubMed Web of Science ®Google Scholar
• Howington JA, Blum MG, Chang AC, et al. Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e278S–e313S. doi:10.1378/chest.12-2359
   PubMed Web of Science ®Google Scholar
• Gouda MA. Common pitfalls in reporting the use of SPSS software. Med Princ Pract. 2015;24(3):300. doi:10.1159/000381953
   PubMed Web of Science ®Google Scholar
• Schoonjans F, Zalata A, Depuydt CE, et al. MedCalc: a new computer program for medical statistics. Comput Methods Programs Biomed. 1995;48(3):257–262. doi:10.1016/0169-2607(95)01703-8
   PubMed Web of Science ®Google Scholar
• Berkman SJ, Roscoe EM, Bourret JC. Comparing self-directed methods for training staff to create graphs using GraphPad Prism. J Appl Behav Anal. 2019;52(1):188–204. doi:10.1002/jaba.522
   PubMed Web of Science ®Google Scholar
• Orozco-Morales M, Soca-Chafre G, Barrios-Bernal P, et al. Interplay between cellular and molecular inflammatory mediators in lung cancer. Mediators Inflamm. 2016;2016:3494608. doi:10.1155/2016/3494608
   PubMed Web of Science ®Google Scholar
• Olingy CE, Dinh HQ, Hedrick CC. Monocyte heterogeneity and functions in cancer. J Leukoc Biol. 2019;106(2):309–322. doi:10.1002/JLB.4RI0818-311R
   PubMed Web of Science ®Google Scholar
• Shibutani M, Maeda K, Nagahara H, et al. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancer. World J Gastroenterol. 2015;21(34):9966–9973. doi:10.3748/wjg.v21.i34.9966
   PubMed Web of Science ®Google Scholar
• Yin W, Lv J, Yao Y, et al. Elevations of monocyte and neutrophils, and higher levels of granulocyte colony-stimulating factor in peripheral blood in lung cancer patients. Thorac Cancer. 2021;12(20):2680–2690. doi:10.1111/1759-7714.14103
   PubMed Web of Science ®Google Scholar
• Kumagai S, Marumo S, Shoji T, et al. Prognostic impact of preoperative monocyte counts in patients with resected lung adenocarcinoma. Lung Cancer. 2014;85(3):457–464. doi:10.1016/j.lungcan.2014.06.015
   PubMed Web of Science ®Google Scholar
• Almasaudi AS, Dolan RD, Edwards CA, et al. Hypoalbuminemia reflects nutritional risk, body composition and systemic inflammation and is independently associated with survival in patients with colorectal cancer. Cancers. 2020;12(7):1986. doi:10.3390/cancers12071986
   PubMed Web of Science ®Google Scholar
• Varim C, Celik FD, Sunu C, et al. The role of neutrophil albumin ratio in predicting the stage of non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2022;26(8):2900–2905. doi:10.26355/eurrev_202204_28621
   PubMed Web of Science ®Google Scholar
• Zhang ZL, Guo QQ, Tang JN, et al. Monocyte-to-albumin ratio as a novel predictor of long-term adverse outcomes in patients after percutaneous coronary intervention. Biosci Rep. 2021;41(7):BSR20210154. doi:10.1042/BSR20210154
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Kawada K, Hida K, et al. Combination of lymphocyte count and albumin concentration as a new prognostic biomarker for rectal cancer. Sci Rep. 2021;11(1):5027. doi:10.1038/s41598-021-84475-4
   PubMed Web of Science ®Google Scholar
• Giese MA, Hind LE, Huttenlocher A. Neutrophil plasticity in the tumor microenvironment. Blood. 2019;133(20):2159–2167. doi:10.1182/blood-2018-11-844548
   PubMed Web of Science ®Google Scholar
• Huang Y, Wei S, Jiang N, et al. The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis. BMC Cancer. 2018;18(1):1235. doi:10.1186/s12885-018-5136-5
   PubMedGoogle Scholar
• Mori K, Janisch F, Mostafaei H, et al. Prognostic value of hemoglobin in metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis. Clin Genitourin Cancer. 2020;18(4):e402–e409. doi:10.1016/j.clgc.2019.12.002
   PubMed Web of Science ®Google Scholar
• Magrowski Ł, Masri O, Ciepał J, et al. Pre-treatment hemoglobin concentration and absolute monocyte count as independent prognostic factors for survival in localized or locally advanced prostate cancer patients undergoing radiotherapy. Biomedicines. 2022;10(10):2514. doi:10.3390/biomedicines10102514
   PubMed Web of Science ®Google Scholar
• Dong Y, Wang H, Shan D, et al. Research progress on the relationship between blood lipids and lung cancer risk and prognosis. Zhongguo Fei Ai Za Zhi. 2020;23(9):824–829. doi:10.3779/j.issn.1009-3419.2020.102.36
   PubMedGoogle Scholar
• Rossi E, Aieta M, Tartarone A, et al. A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients. Transl Lung Cancer Res. 2021;10(1):80–92. doi:10.21037/tlcr-20-855
   PubMed Web of Science ®Google Scholar
• Pezzuto A, D’Ascanio M, Ricci A, et al. Expression and role of p16 and GLUT1 in malignant diseases and lung cancer: a review. Thorac Cancer. 2020;11(11):3060–3070. doi:10.1111/1759-7714.13651
   PubMed Web of Science ®Google Scholar
• Mazzella A, Maiolino E, Maisonneuve P, et al. Systemic inflammation and lung cancer: is it a real paradigm? Prognostic value of inflammatory indexes in patients with resected non-small-cell lung cancer. Cancers. 2023;15(6):1854. doi:10.3390/cancers15061854
   PubMed Web of Science ®Google Scholar
• Khanmohammadi A, Aghaie A, Vahedi E, et al. Electrochemical biosensors for the detection of lung cancer biomarkers: a review. Talanta. 2020;206:120251. doi:10.1016/j.talanta.2019.120251
   PubMed Web of Science ®Google Scholar